Dahlen T, Edgren G, Ljungman P, Flygt H, et al. Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002-2017 in a complete coverage and nationwide agnostic register study. Am J Hematol 2022 Jan 11. doi: 10.1002/ajh.26463.
PMID: 35015312